Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate
- PMID: 28547870
- DOI: 10.1111/jcpt.12538
Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate
Abstract
What is known and objective: Massive acute arsenic poisoning is rare yet potentially life-threatening. 2,3-dimercaptopropane-1-sulphonate (DMPS) appears to have the appropriate chelating property. However, clinical experience on the use of DMPS in massive arsenic poisoning is limited.
Case description: A 37-year-old woman attempted suicide by ingesting 37.5 g of arsenic trioxide. DMPS was promptly initiated based on history and clinical symptoms. The patient recovered completely, with no complications or side effects of the therapy.
What is new and conclusion: TDMPS is useful for the treatment of massive acute arsenic poisoning.
Keywords: 2,3-dimercaptopropane-1-sulphonate; arsenic; arsenic poisoning; chelation therapy.
© 2017 John Wiley & Sons Ltd.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
